首页 | 本学科首页   官方微博 | 高级检索  
检索        

参麦注射液保护氧化损伤心肌细胞线粒体的机制研究
引用本文:赵誉,张凤,赵筱萍,袁玮,张金华,王毅.参麦注射液保护氧化损伤心肌细胞线粒体的机制研究[J].浙江大学学报(医学版),2018,47(5):507-513.
作者姓名:赵誉  张凤  赵筱萍  袁玮  张金华  王毅
作者单位:1. 浙江大学药物信息学研究所, 浙江 杭州 3100582. 浙江中医药大学基础医学院, 浙江 杭州 3100533. 云南大理药业股份有限公司, 云南 大理 671000
基金项目:国家自然科学基金(81822047);浙江省自然科学基金(LR16H280001);浙江大学基本科研业务费专项资金(2017FZA7015);浙江大学曹光彪高科技发展基金(2017RC016)
摘    要:目的: 探究参麦注射液对氧化损伤心肌细胞的保护作用及其对线粒体能量代谢过程的影响。方法: 采用叔丁基过氧化氢(t-BHP)诱导构建H9c2心肌细胞氧化损伤模型。分别采用MTT法和化学发光法检测参麦注射液对细胞存活率和ATP水平的影响;采用Clark氧电极检测参麦注射液对细胞有氧呼吸速率的调节作用;采用ELISA法检测丙酮酸及丙酮酸脱氢酶(PDH)的含量及活性;采用蛋白质印迹法检测丙酮酸脱氢酶亚基(PDHA1)含量;采用实时定量RT-PCR检测丙酮酸脱氢酶激酶1(PDK1)mRNA的表达。结果: 与氧化损伤模型比较,参麦注射液可有效提高心肌细胞存活率和ATP水平(均P < 0.01),提高细胞氧呼吸速率,减少丙酮酸含量,并提高PDH活性(P < 0.05或P < 0.01)。在分子水平上,参麦注射液可提高PDHA1蛋白表达(P < 0.05),并具有降低PDK1 mRNA表达的趋势(P>0.05)。结论: 参麦注射液可有效保护氧化损伤心肌细胞,其机制可能与提高PDH活性、减少丙酮酸堆积,从而维持线粒体功能稳定和细胞能量代谢稳定有关。

关 键 词:肌细胞    心脏/药物作用  肌细胞    心脏/病理学  线粒体    心脏/病理学  氧/代谢  丙酮酸脱氢酶(硫辛酰胺)  麦冬/药理学  人参/药理学  
收稿时间:2018-03-08

Shenmai injection protects mitochondria from oxidative injury in myocardial cells and its mechanism
ZHAO Yu,ZHANG Feng,ZHAO Xiaoping,YUAN Wei,ZHANG Jinhua,WANG Yi.Shenmai injection protects mitochondria from oxidative injury in myocardial cells and its mechanism[J].Journal of Zhejiang University(Medical Sciences),2018,47(5):507-513.
Authors:ZHAO Yu  ZHANG Feng  ZHAO Xiaoping  YUAN Wei  ZHANG Jinhua  WANG Yi
Institution:1. Institute of Pharmaceutical Informatics, Zhejiang University, Hangzhou 310058, China2. School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China3. Dali Pharmaceutical Co., Ltd., Dali 671000, Yunnan Province, China
Abstract:Objective: To investigate the effect of Shenmai injection on myocardial cells with oxidative injury and the underlying mechanisms. Methods: Tert-butyl hydroperoxide (t-BHP) was used to induce the oxidative stress in H9c2 myocardial cells. The cell viability and ATP level were evaluated using MTT-colorimetric method and CellTiter-Glo luminescent cell viability assay. The oxygen respiration rate was examined by Clark oxygen electrode. Pyruvate and pyruvate dehydrogenase (PDH) levels were evaluated by ELISA kit. Western blot and quantitative real-time RT-PCR were employed to evaluate the expression of pyruvate dehydrogenase alpha 1(PDHA1) and pyruvate dehydrogenase kinase 1(PDK1). Results: Shenmai injection significantly improved viability and respiration of H9c2 myocardial cells after t-BHP injury (P < 0.05 or P < 0.01). It increased ATP contents by consuming pyruvate and increasing PDH level (P < 0.05 or P < 0.01). Furthermore, Shenmai injection had the tendency to increase protein expression of PDHA1(P < 0.05) and decrease mRNA expression of PDK1 (P>0.05). Conclusion: Shenmai injection protects mitochondria from oxidative stress by increasing PDH level, which indicates that it may improve energy metabolism of myocardial cells.
Keywords:Myocytes  cardiac/drug effects  Myocytes  cardiac/pathology  Mitochondria  heart/pathology  Oxygen/metabolism  Pyruvate dehydrogenase(lipoamide)  Ophiopogon japonicus/pharmacology  Ginseng/pharmacology  
点击此处可从《浙江大学学报(医学版)》浏览原始摘要信息
点击此处可从《浙江大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号